These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11149304)

  • 1. Non-alcoholic steatohepatitis in children and adolescents.
    Manton ND; Lipsett J; Moore DJ; Davidson GP; Bourne AJ; Couper RT
    Med J Aust; 2000 Nov; 173(9):476-9. PubMed ID: 11149304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
    Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
    Gudowska M; Wojtowicz E; Cylwik B; Gruszewska E; Chrostek L
    Adv Clin Exp Med; 2015; 24(5):823-7. PubMed ID: 26768633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis.
    Luyckx FH; Scheen AJ; Lefèbvre PJ
    Lancet; 1999 Oct; 354(9186):1298-9. PubMed ID: 10520658
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non alcoholic steatohepatitis].
    Manero E; Findor JA; Avagnina A; de Elizalde S; Elsner B
    Medicina (B Aires); 1994; 54(6):625-9. PubMed ID: 7658998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity.
    Stratopoulos C; Papakonstantinou A; Terzis I; Spiliadi C; Dimitriades G; Komesidou V; Kitsanta P; Argyrakos T; Hadjiyannakis E
    Obes Surg; 2005 Sep; 15(8):1154-60. PubMed ID: 16197789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic steatohepatitis: a childhood case].
    Tokodi I; Molnár A; Reiber I; Simon G
    Orv Hetil; 2002 Aug; 143(32):1899-903. PubMed ID: 12221996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity.
    Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ
    Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis.
    Susca M; Grassi A; Zauli D; Volta U; Lenzi M; Marchesini G; Bianchi FB; Ballardini G
    Dig Liver Dis; 2001 Dec; 33(9):768-77. PubMed ID: 11838612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.
    Pinto HC; Baptista A; Camilo ME; Valente A; Saragoça A; de Moura MC
    Dig Dis Sci; 1996 Jan; 41(1):172-9. PubMed ID: 8565753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)?
    Romero FP
    Rev Esp Enferm Dig; 2009 Aug; 101(8):521-7. PubMed ID: 19785490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruptured hepatocellular carcinoma in a patient with nonalcoholic steatohepatitis.
    Smith BM; Hussain A; Jacobs M; Merrick HW
    Surg Obes Relat Dis; 2009; 5(4):510-2. PubMed ID: 19342313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.